Loading…
Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial
Eighty Japanese children, aged 8–12 years, with a spherical equivalent refraction (SER) of − 1.00 to − 6.00 dioptres (D) were randomly allocated into two groups to receive either a combination of orthokeratology (OK) and 0.01% atropine solution (combination group) or monotherapy with OK (monotherapy...
Saved in:
Published in: | Scientific reports 2020-07, Vol.10 (1), p.12750, Article 12750 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Eighty Japanese children, aged 8–12 years, with a spherical equivalent refraction (SER) of − 1.00 to − 6.00 dioptres (D) were randomly allocated into two groups to receive either a combination of orthokeratology (OK) and 0.01% atropine solution (combination group) or monotherapy with OK (monotherapy group). Seventy-three subjects completed the 2-year study. Over the 2 years, axial length increased by 0.29 ± 0.20 mm (
n
= 38) and 0.40 ± 0.23 mm (
n
= 35) in the combination and monotherapy groups, respectively (
P
= 0.03). Interactions between combination treatment and age or SER did not reach significance level (age,
P
= 0.18; SER,
P
= 0.06). In the subgroup of subjects with an initial SER of − 1.00 to − 3.00 D, axial length increased by 0.30 ± 0.22 mm (
n
= 27) and 0.48 ± 0.22 mm (
n
= 23) in the combination and monotherapy groups, respectively (
P
= 0.005). In the − 3.01 to − 6.00 D subgroup, axial length increased by 0.27 ± 0.15 mm (
n
= 11) and 0.25 ± 0.17 mm (
n
= 12) in the combination and monotherapy groups, respectively (
P
= 0.74). The combination therapy may be effective for slowing axial elongation, especially in children with low initial myopia. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-020-69710-8 |